文献速递自身炎症与 IgG4 相关病

新型Majeed综合征LPIN2突变将骨炎症与炎性M2巨噬细胞及加速破骨细胞生成联系起来

Novel Majeed Syndrome-Causing LPIN2 Mutations Link Bone Inflammation to Inflammatory M2 Macrophages and Accelerated Osteoclastogenesis.
PubMed 文献 · Arthritis Rheumatol · 2021-05-09

该研究在一名4岁Majeed综合征女孩中鉴定出两个新型复合杂合LPIN2致病突变,并发现LPIN2缺陷驱动促炎性M2样巨噬细胞分化及增强破骨细胞生成,从而将Majeed综合征与其他IL-1介导的自身炎症性疾病区分开来。

要点

  • 报告两个新型LPIN2复合杂合突变:母源17.8-kb缺失和父源p.R517H剪接位点突变。
  • LPIN2缺陷促进M2样巨噬细胞释放破骨细胞生成介质并加速破骨细胞生成。
  • JNK抑制和IL-1阻断(而非IL-6阻断)可部分逆转加速的破骨细胞生成。

核心结论

  • LPIN2缺陷驱动促炎性M2样巨噬细胞分化并增强内在破骨细胞生成,为无菌性骨髓炎发病机制提供模型。

研究设计与样本

  • 对一名4岁女性Majeed综合征患者进行靶向基因分析和功能研究,评估单核细胞反应、巨噬细胞分化和破骨细胞生成,并与NOMID、DIRA患者及健康对照比较。

主要发现

  • 患者携带母源LPIN2 17.8-kb缺失和父源p.R517H剪接位点突变,后者可变剪接外显子10和11。
  • 患者接受canakinumab(IL-1阻断)获得长期缓解。
  • 患者及NOMID、DIRA患者的单核细胞和单核细胞来源M1样巨噬细胞caspase 1活性和IL-1β分泌升高。
  • LPS刺激后,患者单核细胞来源M2样巨噬细胞释放的破骨细胞生成介质(IL-8、IL-6、TNF、CCL2、MIP-1α/β、CXCL8、CXCL1)高于NOMID患者和健康对照。
  • 患者加速的破骨细胞生成与NFATc1水平升高、JNK/MAPK增强及Src激酶活化降低相关,并对JNK抑制和IL-1阻断(而非IL-6阻断)部分响应。

临床怎么用

  • 对早发性无菌性骨髓炎伴急性期反应物升高的患者应考虑Majeed综合征及LPIN2基因检测。
  • IL-1阻断(如canakinumab)可使Majeed综合征患者获得长期缓解。
  • JNK抑制和IL-1阻断可能部分改善LPIN2缺陷相关的加速破骨细胞生成。

局限性

  • 研究基于单例患者,结论的普遍性需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify novel heterozygous LPIN2 mutations in a patient with Majeed syndrome and characterize the pathomechanisms that lead to the development of sterile osteomyelitis. METHODS: Targeted genetic analysis and functional studies assessing monocyte responses, macrophage differentiation, and osteoclastogenesis were conducted to compare the pathogenesis of Majeed syndrome to interleukin-1 (IL-1)-mediated diseases including neonatal-onset multisystem inflammatory disease (NOMID) and deficiency of the IL-1 receptor antagonist (DIRA). RESULTS: A 4-year-old girl of mixed ethnic background presented with sterile osteomyelitis and elevated acute-phase reactants. She had a 17.8-kb deletion on the maternal LPIN2 allele and a splice site mutation, p.R517H, that variably spliced out exons 10 and 11 on the paternal LPIN2 allele. The patient achieved long-lasting remission receiving IL-1 blockade with canakinumab. Compared to controls, monocytes and monocyte-derived M1-like macrophages from the patient with Majeed syndrome and those with NOMID or DIRA had elevated caspase 1 activity and IL-1β secretion. In contrast, lipopolysaccharide-stimulated, monocyte-derived, M2-like macrophages from the patient with Majeed syndrome released higher levels of osteoclastogenic mediators (IL-8, IL-6, tumor necrosis factor, CCL2, macrophage inflammatory protein 1α/β, CXCL8, and CXCL1) compared to NOMID patients and healthy controls. Accelerated osteoclastogenesis in the patient with Majeed syndrome was associated with higher NFATc1 levels, enhanced JNK/MAPK, and reduced Src kinase activation, and partially responded to JNK inhibition and IL-1 (but not IL-6) blockade. CONCLUSION: We report 2 novel compound heterozygous disease-causing mutations in LPIN2 in an American patient with Majeed syndrome. LPIN2 deficiency drives differentiation of proinflammatory M2-like macrophages and enhances intrinsic osteoclastogenesis. This provides a model for the pathogenesis of sterile osteomyelitis which differentiates Majeed syndrome from other IL-1-mediated autoinflammatory diseases.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Bhuyan F, de Jesus AA, Mitchell J, et al. Novel Majeed Syndrome-Causing LPIN2 Mutations Link Bone Inflammation to Inflammatory M2 Macrophages and Accelerated Osteoclastogenesis. Arthritis Rheumatol. 2021. PMID: 33314777. doi:10.1002/art.41624

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。